CVS Health (CVS) reported its Q2 2026 financial results before the market open on August 5, 2026. The company achieved a revenue of 106,096 million USD and an earnings per share (EPS) of 2.58 USD, beating the analyst estimate of 1.85 USD by 39.1%. Following the release, the stock price fell by 5.08%.
Generated automatically from our data — as of August 19, 2026
Key figures at a glance
Estimate (EPS): 1.85 USD
Reported (EPS): 2.58 USD
Price reaction: -5.1%
Frequently asked questions
Did CVS Health beat or miss earnings-per-share expectations?
CVS Health beat the analyst estimate of 1.85 USD earnings per share (Q2 2026) by 39.1%, reporting 2.58 USD.
How did CVS Health stock react to the earnings report?
CVS Health stock fell 5.1% on the trading day following the release.
What was CVS Health's revenue in Q2 2026?
CVS Health reported revenue of 106,096M USD in Q2 2026.